1Taki W, Yonekawa Y, Iwata H, et al. A new liquid material for embolization of arteriowenous malformations [ J ]. AJNR, 1990,11 ( 1 ) : 163- 168.
2Jahan R, Murayama Y, Pierre YP, et al. Embolization of arteriowenous malformations with Onyx : clinicopathological experience in 23 patients [ J ], Neurosurgery, 2001,48 ( 5 ) : 984 -996.
3Fournier D,TerBrugge KG, Willinsky R, et al. Endovascular treatment of intracerebral arteriowenous malformation: experience in 49 cases [ J ]. J Neurosurg, 1991,75:228-233.
4Debrun GM, Aletich V, Ausman JI, et al. Embolization of nidus of brain arteriovenous malformations with n-butyl cyanoacrylate [ J ]. Neurosurgery, 1997,40 : 112-121.
5Akin ED, Perkins E, Ross IB. Surgircal handling characteristics of an ethylene vinyl alcohol copolymer compared with N-butyl cyanoacrylate used for embolization of vessels in an arteriovenous malformation resection model in swine[J]. J Neurosurg,2003,98(2) :366-370.
7Cekrige S, Arat A, Soatei L, et al. Long intranidal injections of Onyx in the endovascular treatment of Brain AVMs [ M ]. Presented of the 6th Congress of World Federation of Interventional and Therapeutic Neuroradiology (WFITN) ,2001. 102-103.
8Chaloupka JC, Vinuela F, Vinters HV, et al. Technical feasibility and histopathologic studies of ethylene vinyl copolymer (EVAL) using a swine endovascular embolization model [ J ]. AJNR, 1994, 15 (7) : 1170-1175.
9Chaloupka JC, Huddle DC, Alderman J, et al. A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model [ J ]. AJNR, 1999,20 ( 3 ) :401-410.
2[1]Duffner F,Ritz R,Bornemann A,et al.Combined therapy of cerebral arteriovenous malformations:histological differences between a non-adhesive liquid embolic agent and NBCA[J].Clin Neuropathol,2002,21:13.
3[2]Jahan R,Murayama Y,Gobin YP,et al.Embolization of arteriovenous malformations with Onyx:clinicopathological expeirence in 23 patients[J].Neurosurgery,2001,48:984.
4[3]Murayama Y,Vinuela F,Duckwiler G,et al.Non-adhesive liquid embolic agent for the treatment of cerebral AVM:clinical results at UCLA[J].Intervent Neuroradiol,1999,5:78.
5[4]Murayama Y,Vinuela F,Tateshima S,et al.Endovascular treatmant experimental aneurysms by use of a combination of liquid embolic agents and protective devices[J].AJNR,2000,21:1726.
6[5]Sugiu K,Nishill A,Ktsumata A,et al.The long term follow-up of patients treated with liquid emboli agent dissolved in Dimethy sulfoxide(DMSO).Presented at the 6th Congress of World Federation of Interventional and Therapeutic Neuroradiology(WFITN)[M].Seoul,Science Press,2001.101～102.
7[6]Thompson RC,Gary K,Richard PL,et al.The management of patients with arteriovenous malformations and associated intracranial aneurysms[J].Neurosurgery,1998,43:202.
8[7]Westphal M,Grzyska U.Clinical significance of pedicle aneurysms on feeding vessels,especially those located in infratentorial arteriovenous malformations[J].J Neurosurg,2000,92:995.
9[8]Cekrige S,Arat A,Soatei L,et al.Long intranidal injection of Onyx in the endovascular treatment of Brain AVMs[J].Presented at the 6th Congress of World Federation of Interventional and Therapeutic Neuroradiology(WFITN),2001,102.
10[10]Weber W,Kis B,Siekmann R,et al.Endovascular treatment of intracranial arteriovenous malformations with Onyx:technical aspects[J].Am J Neuroradiol,2007,28:371.
